The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...
Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD) hasn't made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate ...
Sexual side effects have emerged as a major clinical concern with many of the newer antidepressants. Approximately 30% to 40% of patients on serotonergic antidepressants experience sexual dysfunction.
Editor’s note: Dr. Jill Grimes is author of “The Ultimate College Student Health Handbook: Your Guide for Everything From Hangovers to Homesickness.” Grimes has more than 30 years of ...
Medical professionals have been asked to suspend prescribing Prozac to new patients and assist them to prescribe alternatives, the company added. A pack of Eli Lilly and Co antidepressants is pictured ...
Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.